AusPAR: Lenalidomide

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

12 February 2016
AusPAR Details
AusPAR
AusPAR: Lenalidomide (pdf, 1 MB)
AusPAR: Lenalidomide (docx, 1 MB)
Attachment: Product Information: Lenalidomide (pdf, 459 KB)
Attachment: Product Information: Lenalidomide (docx, 142 KB)
Attachment: Extract from Clinical Evaluation Report: Lenalidomide (pdf, 5 MB)
Attachment: Extract from Clinical Evaluation Report: Lenalidomide (docx, 7 MB)
Active Ingredient
Lenalidomide
Product Name
Revlimid
Sponsor
Celgene Pty Ltd
Submission Number
PM-2014-02792-1-4
Submission Type
Extension of indications, New strength
Decision
Approved
AusPAR Date
5 February 2016
Publication Date

12 February 2016
Category: 
Prescription medicines
Tags: 
AusPARs
URL: 
https://www.tga.gov.au/node/713786